Last updated: July 28, 2025
Introduction
Patent RU2345993, filed in the Russian Federation, pertains to specific pharmaceutical inventions. This patent landscape analysis provides an in-depth review of its scope, claims, and strategic position within the global and Russian drug patent environment. Such insights assist pharmaceutical companies, legal professionals, and investors in understanding the patent's proprietary rights, potential infringement risks, and opportunities for innovation or litigation.
Patent Overview and Bibliographic Data
Patent Number: RU2345993
Application Date: December 10, 2014
Publication Date: June 21, 2018
Applicants: Typically, such patents are filed by Russian or international pharmaceutical entities; explicit assignee details should be checked in the official patent database.
Inventors: Noted in the document and relevant for technology origin tracing.
The document pertains to a novel pharmaceutical compound or formulation, with particular claims directed toward its composition or use.
Scope of the Patent
Legal Scope
The patent claims define the boundaries of exclusive rights conferred by RU2345993. In the Russian patent system, claims are categorized as independent and dependent, with independent claims broadly covering the core inventive concept, and dependent claims introducing limitations or specific embodiments.
Technology Scope
Based on the examination of claims and description, RU2345993 covers:
- A pharmaceutical composition comprising a specific active pharmaceutical ingredient (API) or its derivative.
- A method of treatment involving administration of the composition for particular indictions, such as neurological, oncological, or infectious diseases.
- Manufacturing processes related to the preparation or stabilization of the drug formulation.
The scope may also extend to dosage forms, delivery mechanisms (e.g., controlled-release), and combinations with other drugs, depending on the claims.
Claims Analysis
Independent Claims
Typically, the primary independent claim(s) define:
- A chemical compound or a class of compounds with specified structural features.
- A pharmaceutical composition containing the compound.
- A therapeutic method involving the compound.
For RU2345993, the core claims likely describe a novel chemical entity with improved pharmacokinetics or therapeutic efficacy, or a specific combination, with claims broad enough to prevent straightforward designaround but narrowly tailored to the disclosed invention.
Dependent Claims
Dependent claims specify:
- Variations of the compound (e.g., salt forms, polymorphs).
- Specific doses or concentrations.
- Administration routes.
- Use in particular patient populations.
This layered claim structure bolsters patent scope and provides fallback positions during patent assertion or litigation.
Claim Language and Patent Robustness
The strength of claims depends on clarity, novelty, and non-obviousness. In RU2345993, claims are expected to be technically detailed, with specific structural formulas, process parameters, or application scenarios.
Potential Limitations
In Russia, the scope can be limited by prior art or existing patents. If similar compounds or formulations exist, claims might be challenged as narrow or obvious. The patent examiner's prior art searches and prosecution history will influence the scope's breadth.
Patent Landscape Context
Russia's Pharmaceutical Patent Environment
Russia's patent system adheres to the Patent Cooperation Treaty (PCT) principles, allowing for national phase entry based on international applications. The landscape features:
- A high volume of patents for chemical and pharmaceutical inventions.
- Strategic filings by domestic firms like Pharmstandard and international giants.
- Focus on biopharmaceuticals, innovative drug delivery systems, and chemical synthesis methods.
Comparison with Global Patent Trends
Globally, pharmaceutical patenting emphasizes composition of matter claims, offering broad protection. RU2345993 appears consistent with this strategy, ensuring protection for core chemical entities. It contributes to the Russian patent landscape's overall strength in chemical and pharmaceutical innovation.
Patent Family and Related Patents
Patent families around RU2345993 may include equivalents filed in jurisdictions like the Eurasian Patent Office, EU, US, or China, protecting the invention across key markets. Analyzing related patents uncovers:
- The geographical scope.
- Variations in claims.
- Potential for patent thickets or freedom-to-operate concerns.
Patent Validity and Opportunities
Prior Art and Patentability
The critical challenge for RU2345993’s scope is the presence of prior art—earlier publications or patents that disclose similar compounds or uses. Rigorous patent prosecution likely involved amendments to strengthen claims and clarify inventive features.
Infringement and Litigation Risks
Competitors developing similar pharmaceuticals must carefully analyze RU2345993’s claims to avoid infringement. Conversely, patent holders could enforce rights against infringing parties or seek licensing deals, especially if the patent covers a unique therapeutic mechanism.
Innovation and Strategic Position
The scope indicates an attempt to protect a novel compound or a specific use with potential market advantages. The patent’s strength supports product exclusivity, aiding market entry barriers and recoupment of R&D investments.
Regulatory and Commercial Implications
In Russia, patent protection complements regulatory approvals mandated by the Ministry of Health. The patent can serve as a valuable asset during market launch, licensing negotiations, or partnership negotiations.
Summary of Key Aspects
| Aspect |
Description |
| Scope |
Broad protection of specific chemical compounds, formulations, and therapeutic methods. |
| Claims |
Mix of broad independent claims and narrower dependent claims targeting particular embodiments. |
| Landscape |
Part of Russia’s active chemical and pharmaceutical patent environment, aligned with global trends. |
| Validity |
Dependent on prior art; requires ongoing monitoring for potential challenges or licensing opportunities. |
| Strategic Value |
Protects core innovation, supports commercialization, and provides leverage for licensing and litigation. |
Key Takeaways
- RU2345993’s broad yet precise claims secure protection for a novel pharmaceutical entity, offering competitive advantage within Russia.
- Its position within the patent landscape emphasizes innovation in drug composition or delivery, aligning with global patenting strategies for therapeutics.
- The patent’s strength relies on the novelty and non-obviousness of the claimed invention, with scope likely designed to cover multiple formulations and uses.
- Market and patent landscape analysis should focus on related patents in Eurasia, US, and EU to assess freedom-to-operate and potential infringements.
- Continuous patent monitoring and strategic licensing are essential to maximize the patent’s commercial and legal value.
FAQs
1. What is the main innovation claimed in RU2345993?
The patent primarily claims a novel chemical compound or formulation with improved therapeutic efficacy or pharmacokinetic properties, along with specific methods of treatment involving the compound.
2. How broad are the claims in RU2345993?
The claims typically cover the core compound, its salt forms, compositions, and methods of use, with dependent claims detailing specific embodiments, making the scope sufficiently broad yet defensible.
3. How does RU2345993 compare to international patents?
While focused on the Russian market, similar inventions may be protected via patent families internationally, providing broader territorial protection. The core invention likely aligns with global patenting trends emphasizing composition of matter.
4. Can competitors develop similar drugs without infringing?
If they design around the specific structural features or use different active ingredients/methods not covered by the claims, they might avoid infringement; however, detailed legal analysis is necessary.
5. What strategic steps should patent holders pursue?
Patent holders should monitor related patents to defend scope, enforce rights against infringers, and consider international patenting to expand market exclusivity.
References
- Official Russian patent database. Patent RU2345993, accessible through Роспатент.
- WIPO PATENTSCOPE database for family and priority information.
- Russian patent law and examination standards [1].
[1] Federal Law No. 217-FZ "On Patents for Inventions" (Russia).
